A nontoxic strontium nanoparticle that holds the potential to act upon osteocompetent cells: An in vitro and in vivo characterization.

Estrogen deficiency, long-term immobilization, and/or aging are commonly related to bone mass loss, thus increasing the risk of fractures. One option for bone replacement in injuries caused by either traumas or pathologies is the use of orthopedic cement based on polymethylmethacrylate (PMMA). Nevertheless, its reduced bioactivity may induce long-term detachment from the host tissue, resulting in the failure of the implant. In view of this problem, we developed an alternative PMMA-based porous cement (pPMMA) that favors cell invasion and improves osteointegration with better biocompatibility. The cement composition was changed by adding bioactive strontium-nanoparticles that mimic the structure of bone apatite. The nanoparticles were characterized regarding their physical-chemical properties, and their effects on osteoblasts and osteoclast cultures were assessed. Initial in vivo tests were also performed using 16 New Zealand rabbits as animal models, in which the pPMMA-cement containing the strontium nanoparticles were implanted. We showed that the apatite nanoparticles in which 90% of Ca2+ ions were substituted by Sr2+ (NanoSr 90%) upregulated TNAP activity and increased matrix mineralization. Moreover, at the molecular level, NanoSr 90% upregulated the mRNA expression levels of, Sp7, and OCN. Runx2 was increased at both mRNA and protein levels. In parallel, in vivo tests revealed that pPMMA-cement containing NanoSr 90%, upregulated two markers of bone maturation, OCN and BMP2, as well as the formation of apatite minerals after implantation in the femur of rabbits. The overall data support that strontium nanoparticles hold the potential to up-regulate mineralization in osteoblasts when associated with synthetic biomaterials.

Biosynthesis of Strontium Nanoparticles Using Mimosa pudica and its Antioxidant Effect.

A new area of nanotechnology, "green synthesis" studies nanomaterials utilizing natural biomaterials like plants, flowers, and microbesGreen nanoparticle synthesis offers various benefits, such as cost efficiency, pollution reduction, and environmental compatibility. Among nanoparticles, metallic variants have garnered the greatest attention due to their unique physical and chemical attributes. Strontium (Sr), known for promoting growth, aiding bone regeneration, and stimulating calcium signaling, holds significance in the medical domain. Consequently, Sr-based nanoparticles have gained interest in medical and dental applications due to their resemblance to calcium properties. Researchers worldwide are drawn to Mimosa pudica because of its pharmacological properties, including its ability to treat wounds, and its anti-diabetic, anti-toxin, anti-hepatotoxin, and antioxidant effects. Mimosa pudica mediated strontium nanoparticles' antioxidant activity was tested against FRAP assay, H2O2 assay, and DPPH assay with ascorbic acid as standard, where in all three assays, increasing concentration of Mimosa pudica mediated strontium nanoparticles exhibited increasing antioxidant activity which was similar to the ascorbic acid. Hence, this can be used as a novel antioxidant agent in the near future.

Evaluation of Antidiabetic Activity and Cytotoxic Effect of Strontium Nanoparticles Synthesized Using Mimosa Pudica.

Nanotechnology is emerging as a promising approach in the development of novel therapeutic strategies. Nanoparticles, due to their unique physicochemical properties and small size, have the potential to improve the delivery of therapeutic agents, enhance their bioavailability, and increase their efficacy. Among various types of nanoparticles, strontium nanoparticles have gained attention due to their potential antidiabetic activity and cytotoxic effects against cancer cells. Mimosa pudica, also known as "Sensitive Plant" or "Touch-Me-Not," is a medicinal plant known for its diverse pharmacological activities, including antidiabetic and anticancer properties. Recent research has focused on the synthesis of strontium nanoparticles by using Mimosa pudica as a green and sustainable approach. These nanoparticles have shown promising results in terms of their antidiabetic activity and cytotoxic effects against cancer cells. Thus, in this study, the antidiabetic effect was studied using the alpha-amylase inhibitor assay, and the cytotoxic effect was studied using the brine shrimp lethality assay. In these assays, increasing concentration of Mimosa pudica-mediated strontium nanoparticles exhibited increasing antidiabetic and cytotoxic effects, which was similar to the standard used, which is acarbose. Hence, this can be used as a novel antidiabetic and cytotoxic agent in the future.

Green Synthesis of Mimosa pudica-Mediated Strontium Nanoparticles and its Anti-Inflammatory Activity.

Background: Considerable focus has been directed toward green synthesis as a dependable, sustainable, and environmentally friendly approach for synthesizing various nanomaterials. Mimosa pudica, a quickly grown pantropical weed, has been used widely for its anti-inflammatory and antimicrobial activity in traditional medicine. The development of strontium-based nanoparticles and nanoparticles linked with strontium has garnered attention in recent years due to their established utility in diverse domains such as effective drug distribution, bioimaging, cancer treatment, and advancements in bone engineering. Aims and Objectives: To examine the green synthesise of strontium nanoparticles using Mimosa pudica and its anti-inflammatory activity. Material and Methods: Mimosa pudica-mediated strontium nanoparticles' anti-inflammatory activity was tested using bovine serum albumin denaturation assay, egg albumin denaturation assay, and membrane stabilization assay with diclofenac sodium as the standard. Result: In all three assays, increasing concentration of Mimosa pudica-mediated strontium nanoparticles exhibited an increasing anti-inflammatory effect, which was similar to the standard diclofenac sodium. Conclusion: Consequently, this holds promise as a new potential anti-inflammatory agent in forthcoming applications.

Green Synthesis of Selenium, Zinc Oxide, and Strontium Nanoparticles and Their Antioxidant Activity - A Comparative In Vitro Study.

Background Antioxidants are vital in reducing oxidative stress, a key factor in the pathogenesis of many chronic diseases, including cancer, cardiovascular disease, and neurodegenerative disorders. The aim of our study is to analyze and compare the oxidative potential of biosynthesized selenium, strontium, and zinc oxide nanoparticles (NPs). Materials and methods Selenium nanoparticles (SeNPs) were synthesized using 20 mM of sodium selenite as the precursor and 1 g each of Cymbopogon citratus and Syzygium aromaticum as reducing and stabilizing agents. Strontium nanoparticles (SrNPs) were synthesized with 30 mM of strontium chloride as the precursor and 1 g of Acacia nilotica as a reducing and stabilizing agent. Zinc oxide nanoparticles (ZnONPs) were synthesized using 30 mM of zinc nitrate as the precursor and 1 g each of Cuminum cyminum and Syzygium aromaticum as reducing and stabilizing agents. Selenium, strontium, and zinc oxide nanoparticles were characterized using Fourier-transform infrared spectroscopy (FT-IR) analysis. The antioxidant activity of biogenically synthesized strontium, selenium and zinc oxide nanoparticles was examined using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging assay (DPPH assay) and hydroxyl radical scavenging assay (H2O2 assay). Results The FT-IR spectra of selenium nanoparticles revealed a peak at 3327.990 cm-1, strontium nanoparticles at 3332.331 cm-1, and zinc oxide nanoparticles at 3216.346 cm-1. The significant results for the green-synthesized selenium, strontium, and zinc oxide nanoparticles were observed in antioxidant assays. The results from the DPPH assay show that at the highest concentration of 50 µL, SrNPs exhibited 90.12 % inhibition, SeNPs displayed 90.12% inhibition, and ZnONPs showed 89.55% inhibition. In the H2O2 assay, at the highest concentration of 50 µL, SrNPs showed 87.43% inhibition, SeNPs displayed 85.11% inhibition, and ZnONPs exhibited 84.66% inhibition. SrNPs demonstrated a higher percentage of inhibition in both the DPPH and H2O2 assays. Maximum inhibitory activity was observed at the highest concentration. However, the prepared nanoparticles showed a slightly lower percentage of inhibition when compared to the standard. Conclusion Strontium nanoparticles synthesized based on Acacia nilotica demonstrated excellent antioxidant activity compared to the synthesized selenium and zinc oxide nanoparticles. Therefore, the study suggests that the produced strontium nanoparticles can serve as an antioxidant agent, owing to their remarkable free radical scavenging activity.